juvenile psoriatic arthritis

Janssen, Brickell and ViiV are Knocking on FDA's Door
BioSpace
Sat, 10/9/21 - 10:56 pm
FDA
Janssen
Stelara
juvenile psoriatic arthritis
Brickell Bio
sofpironium bromide gel
ViiV Healthcare
HIV
Triumeq
Janssen announces submission of two applications to US FDA seeking approval of SIMPONI ARIA to treat polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis
Pharmaceutical Business Review
Mon, 04/27/20 - 09:29 am
JNJ
Janssen
FDA
Simponi Aria
polyarticular juvenile idiopathic arthritis
juvenile psoriatic arthritis